ID: ALA5279769

Max Phase: Preclinical

Molecular Formula: C15H17NO4

Molecular Weight: 275.30

Associated Items:

Representations

Canonical SMILES:  O=c1cc(OCCN2CCOCC2)c2ccccc2o1

Standard InChI:  InChI=1S/C15H17NO4/c17-15-11-14(12-3-1-2-4-13(12)20-15)19-10-7-16-5-8-18-9-6-16/h1-4,11H,5-10H2

Standard InChI Key:  YDEKYDSVGJEDFH-UHFFFAOYSA-N

Associated Targets(Human)

Monoamine oxidase B 8835 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 275.30Molecular Weight (Monoisotopic): 275.1158AlogP: 1.50#Rotatable Bonds: 4
Polar Surface Area: 51.91Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.41CX LogP: 0.94CX LogD: 0.90
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.79Np Likeness Score: -0.79

References

1. Manzoor S, Hoda N..  (2020)  A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer's disease agents: A review.,  206  [PMID:32942081] [10.1016/j.ejmech.2020.112787]

Source